Skip to main content
. 2008 Oct 16;337:a1840. doi: 10.1136/bmj.a1840

Table 1.

 Baseline characteristics. Values are medians (interquartile ranges) unless stated otherwise

Characteristics Aspirin plus antioxidant (n=320) Aspirin plus placebo (n=318) Placebo plus antioxidant (n=320) Placebo plus placebo (n=318)
Mean (SD) age (years) 61.0 (10.0) 60.0 (10.1) 60.0 (10.3) 60.1 (9.7)
No (%) women 169 (53) 183 (58) 181 (57) 180 (57)
Time since diagnosis of diabetes (years) 6.7 (2.9-12.9) 6.0 (2.7-13.0) 5.7 (2.4-11.7) 6.4 (2.6-11.6)
No (%) treated with insulin 107 (33) 112 (35) 96 (30) 91 (29)
Smoking status:
 No (%) current smokers 105 (33) 99 (31) 106 (33) 87 (27)
 No (%) former smokers 113 (35) 107 (34) 111 (35) 116 (36)
 No (%) never smokers 102 (32) 112 (35) 103 (32) 115 (36)
Body mass index (kg/m2) 29.7 (26.2-33.3) 28.7 (25.2-33.0) 29.4 (26.1-33.5) 29.2 (25.8-33.2)
Mean (SD) systolic blood pressure (mm Hg) 146 (22) 143 (21) 144 (20) 147 (21)
Mean (SD) diastolic blood pressure (mm Hg) 79 (10) 78 (10) 79 (10) 80 (11)
Ankle brachial pressure index 0.90 (0.82-0.95) 0.91 (0.84-0.95) 0.89 (0.81-0.94) 0.90 (0.83-0.96)
Mean (SD) HbA1c level (%) 8.0 (1.8) 8.0 (1.7) 7.9 (1.8) 7.9 (1.7)
Total cholesterol level (mmol/l) 5.5 (4.8-6.2) 5.6 (4.9-6.2) 5.5 (4.9-6.3) 5.5 (4.9-6.2)
Triglyceride level (mmol/l) 2.2 (1.5-3.2) 2.2 (1.5-3.3) 2.3 (1.4-3.4) 2.1 (1.5-3.3)
High density lipoprotein level (mmol/l) 1.2 (1.0-1.5) 1.3 (1.0-1.5) 1.2 (1.0-1.5) 1.2 (1.0-1.5)
Low density lipoprotein level (mmol/l) 3.1 (2.5-3.7) 3.1 (2.5-3.7) 3.2 (2.6-3.9) 3.1 (2.6-3.7)